These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23769546)

  • 1. Drug treatments in the secondary prevention of ischaemic stroke.
    Schulz UG
    Maturitas; 2013 Nov; 76(3):267-71. PubMed ID: 23769546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke.
    Rothwell PM; Algra A; Amarenco P
    Lancet; 2011 May; 377(9778):1681-92. PubMed ID: 21571151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical prevention of stroke and stroke recurrence in patients with TIA and minor stroke.
    Weber R; Weimar C; Diener HC
    Expert Opin Pharmacother; 2009 Aug; 10(12):1883-94. PubMed ID: 19558342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in clinical neurosciences: pharmacotherapies for the secondary prevention of stroke.
    Hackam DG; Kapral MK
    Can J Neurol Sci; 2004 Aug; 31(3):295-303. PubMed ID: 15376471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities between prescribing of secondary prevention therapies for stroke and coronary artery disease in general practice.
    Heeley E; Anderson C; Patel A; Cass A; Peiris D; Weekes A; Chalmers J
    Int J Stroke; 2012 Dec; 7(8):649-54. PubMed ID: 21978147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent stroke: where do we stand with the secondary prevention of noncardioembolic ischaemic strokes?
    Talelli P; Greenwood RJ
    Ther Adv Cardiovasc Dis; 2008 Oct; 2(5):387-405. PubMed ID: 19124436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal combination secondary prevention drug treatment and stroke outcomes.
    Park JH; Ovbiagele B
    Neurology; 2015 Jan; 84(1):50-6. PubMed ID: 25411440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischemic stroke in patients receiving aspirin.
    Pujol Lereis VA; Ameriso S; Povedano GP; Ameriso SF
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):868-72. PubMed ID: 21703876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation on the compliance with secondary prevention and influence factors of ischemic stroke in Hainan province, China.
    Su Q; Yuan K; Long F; Wan Z; Li C; Cai Y; Zeng C; Wu Y; Wu H; Liu S; Li P; Zhou J; Chen C; Wang D; Yan L; Zhang Y; Dai M
    Vascular; 2014 Jun; 22(3):181-7. PubMed ID: 23929417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary stroke prevention - an update].
    Hamann GF; Röther J
    Fortschr Neurol Psychiatr; 2010 Oct; 78(10):572-81. PubMed ID: 20927689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing strokes: the assessment and management of people with transient ischaemic attack.
    Gommans J; Barber PA; Fink J
    N Z Med J; 2009 Apr; 122(1293):3556. PubMed ID: 19448791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
    Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelets in secondary stroke prevention: should clopidogrel be the first choice?
    Aw D; Sharma JC
    Postgrad Med J; 2012 Jan; 88(1035):34-7. PubMed ID: 22121248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing recurrent cerebrovascular events in patients with stroke or transient ischemic attack: the current data.
    Bergman D
    J Am Acad Nurse Pract; 2011 Dec; 23(12):659-66. PubMed ID: 22145656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action on vascular risk factors: importance of blood pressure and lipid lowering in stroke secondary prevention.
    Fuentes B; Ortega-Casarrubios MA; Martínez P; Díez-Tejedor E
    Cerebrovasc Dis; 2007; 24 Suppl 1():96-106. PubMed ID: 17971644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standard medical management in secondary prevention of ischemic stroke in China (SMART).
    Peng B; Zhu Y; Cui L; Ni J; Xu W; Zhou L; Yao M; Chen L; Wang J; Wang Y; Pu C;
    Int J Stroke; 2011 Oct; 6(5):461-5. PubMed ID: 21951412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary prevention of stroke: a practical guide to drug treatment.
    Koennecke HC
    CNS Drugs; 2004; 18(4):221-41. PubMed ID: 15015903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stroke in chronic renal failure].
    Bereczki D
    Orv Hetil; 2008 Apr; 149(15):691-6. PubMed ID: 18387873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack.
    Davis SM; Donnan GA
    N Engl J Med; 2012 May; 366(20):1914-22. PubMed ID: 22591297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.